Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis-Reference-Cited by-同舟云学术

Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis

Published:2006 Issue:1 Volume:45 Page:62-71
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Mookerjee Rajeshwar P.,Malaki Mohammed,Davies Nathan A.,Hodges Stephen J.,Dalton R. Neil,Turner Charles,Sen Sambit,Williams Roger,Leiper James,Vallance Patrick,Jalan Rajiv

Publisher

Wiley

Subject

Hepatology

Reference38 articles.

1. Current management of alcoholic liver disease

2. Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis

3. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era

4. The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough

5. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOSTRIN is an emerging negative regulator of decompensated cirrhotic patients with portal hypertension;2024-05-07

2. Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-12-18

3. Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF;European Journal of Pharmacology;2023-11

4. Portal Hypertension in Alcohol-Associated Hepatitis;Current Hepatology Reports;2023-04-05

5. Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism;American Journal of Physiology-Gastrointestinal and Liver Physiology;2023-02-01